CVKD

Cadrenal Therapeutics, Inc. Common Stock

Price

$1.57

return (12m)

-88.22%

p/e

-0.40

p/bv

1.12

DIVIDEND YIELD

0.00%

CVKD price

Cadrenal Therapeutics, Inc. Common Stock

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CVKD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-23.10%

3 months

-68.45%

1 year

-88.22%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CVKD

Valuation

P/E

-0.40

Sector 7.65

Industry 7.65

P/BV

1.12

Sector 1.91

Industry 1.91

P/Revenue (PSR)

Sector 1.92

Industry 1.92

EV/EBITDA

Sector -630.62

Industry -630.62

EV/EBIT

Sector -7,206,132,315.43

Industry -7,206,132,315.43

P/EBITDA

-0.50

Sector -92.86

Industry -92.86

P/EBIT

-0.50

Sector -91.56

Industry -91.56

P/Total Assets

0.82

Sector 0.90

Industry 0.90

P/Net Current Assets

1.12

Sector -2.52

Industry -2.52

P/Working Capital

1.12

Sector -4,940.99

Industry -4,940.99

EPS

-3.96

Sector 0.72

Industry 0.72

BVPS

1.40

Sector 9.67

Industry 9.67

Efficiency

Gross Margin

0.00%

Sector 34.42%

Industry 34.42%

EBITDA Margin

Sector 2.06%

Industry 2.06%

EBIT Margin

Sector 0.23%

Industry 0.23%

Operating Margin

0.00%

Sector 4.20%

Industry 4.20%

Net Profit Margins

0.00%

Sector 2.40%

Industry 2.40%

Asset Turnover

Sector 0.11

Industry 0.11

Profitability

ROE

-282.13%

Sector 1.42%

Industry 1.42%

ROA

-206.55%

Sector -0.76%

Industry -0.76%

ROIC

Sector -65.52%

Industry -65.52%

Dividends

Dividend yield

0.00%

Sector 0.49%

Industry 0.49%

Payout

Sector 10.08%

Industry 10.08%

Debt

Current Ratio

3.73

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -109,118,343.39

Industry -109,118,343.39

Net Debt / EBIT

Sector -82.02

Industry -82.02

Net Debt / Equity

Sector -0.79

Industry -0.79

Gross Debt / Equity

Sector -0.39

Industry -0.39

Equity/Assets

0.73

Sector 0.42

Industry 0.42

Liabilities/Assets

0.27

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CVKD

DRAG THE FRAME TO SEE MORE DATA

CVKD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Cadrenal Therapeutics, Inc. Common Stock (United States) is listed on the Nasdaq and has a market capitalization of $4.57 million, with shareholders equity totaling $4.09 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Cadrenal Therapeutics, Inc. Common Stock reported $- in revenue, generating net income of $-11.54 million.

Key financial metrics include a P/E ratio of -0.40, a price-to-book (P/B) ratio of 1.12, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CVKD.

Market cap

$4.57 million

Net worth

$4.09 million

$4,091,708.00

Assets

$5.59 million

$5,588,965.00

Total Shares Outstanding

2.91 million

2,913,000

Average Daily Trading Volume

$68.09 Thousand

$68,090.00

Sector

Others

Industry

Others

CVKD

CVKD revenue and profits

Financial Results CVKD

DRAG THE FRAME TO SEE MORE DATA

CVKD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$394.67 31,55% (12M)

P/E

23.98

2.26%

ROE

14.27%

P/BV

3.42

SHEL - Shell PLC ADR

$90.87 28,85% (12M)

P/E

9.92

3.21%

ROE

14.29%

P/BV

1.42

STLA - Stellantis NV

$5.40 --43,93% (12M)

P/E

-0.59

0.00%

ROE

-35.93%

P/BV

0.21

COR - Cencora Inc.

$322.26 11,56% (12M)

P/E

23.63

0.73%

ROE

81.48%

P/BV

19.25

SSNLF - Samsung Electronics Co Ltd

$65.21 62,28% (12M)

P/E

0.00

0.00%

ROE

7,749.65%

P/BV

0.00

ALIZY - Allianz SE ADR

$51.73 --7,97% (12M)

P/E

14.28

2.63%

ROE

17.89%

P/BV

2.55

TTE - TotalEnergies SE ADR

$86.62 49,34% (12M)

P/E

7.18

4.53%

ROE

21.42%

P/BV

1.54

NSRGY - Nestle SA ADR

$97.10 7,42% (12M)

P/E

12.00

4.01%

ROE

58.05%

P/BV

6.97